Documentos relacionados

1. Treating Helicobacter pylori infection in the face of growing antibiotic resistance.
2. Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial.
3. <i>Helicobacter pylori</i> Antibiotic Resistance: Molecular Basis and Diagnostic Methods.
4. Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates.
5. [Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province].
6. Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets.
7. Antibiotic Resistance of <i>Helicobacter pylori</i> in Patients with Peptic Ulcer.
8. Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysis.
9. Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study.
10. V Spanish Consensus Conference on Helicobacter pylori infection treatment.